GIACOMINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.411
EU - Europa 830
AS - Asia 227
AF - Africa 84
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.556
Nazione #
US - Stati Uniti d'America 1.406
IT - Italia 250
GB - Regno Unito 214
CN - Cina 104
DE - Germania 103
SE - Svezia 82
TG - Togo 45
IN - India 39
IE - Irlanda 36
SG - Singapore 34
FR - Francia 25
VN - Vietnam 22
BG - Bulgaria 20
CI - Costa d'Avorio 20
JO - Giordania 20
RU - Federazione Russa 20
BE - Belgio 17
ZA - Sudafrica 16
CH - Svizzera 14
EE - Estonia 14
UA - Ucraina 14
NL - Olanda 8
CA - Canada 5
GR - Grecia 4
PL - Polonia 4
IR - Iran 3
JP - Giappone 3
NG - Nigeria 3
BR - Brasile 2
FI - Finlandia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
HR - Croazia 1
SA - Arabia Saudita 1
Totale 2.556
Città #
Chandler 210
Fairfield 196
Southend 193
Ashburn 111
Houston 103
Bologna 95
Seattle 93
Wilmington 92
Woodbridge 79
Ann Arbor 71
Cambridge 58
Princeton 46
Lomé 45
Dublin 36
Falls Church 29
Redmond 28
Turin 28
Singapore 25
Dong Ket 21
Abidjan 20
Amman 20
Sofia 20
Westminster 17
Brussels 16
Beijing 15
Bern 13
Nanjing 13
Shenyang 13
Berlin 12
Padova 12
Jinan 10
San Diego 10
Redwood City 9
Saint Petersburg 8
Hebei 7
Rome 7
Des Moines 6
Olalla 6
Trento 6
Boardman 5
Changsha 5
Florence 4
Milan 4
Nanchang 4
Piemonte 4
Rimini 4
Toronto 4
Venezia 4
Zhengzhou 4
Abeokuta 3
Bolzano 3
Cesena 3
Dearborn 3
Forlì 3
London 3
Merone 3
New York 3
Norwalk 3
Paris 3
Andover 2
Ardabil 2
Bühl 2
Christiansburg 2
Ergolding 2
Ferrara 2
Frankfurt am Main 2
Fuzhou 2
Guangzhou 2
Haikou 2
Helsinki 2
Kyoto 2
Leawood 2
Los Angeles 2
Monmouth Junction 2
Orange 2
Parma 2
Pesaro 2
Ravenna 2
Reggio Nell'emilia 2
Shanghai 2
Tianjin 2
Udine 2
Wuxi 2
Anchorage 1
Aprilia 1
Argelato 1
Athens 1
Barsinghausen 1
Bethesda 1
Brindisi 1
Buffalo 1
Chengdu 1
Costa Mesa 1
Córdoba 1
Edinburgh 1
Edmonton 1
Fermo 1
Gainesville 1
Gemünden 1
Genova 1
Totale 1.936
Nome #
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 164
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 142
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 139
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 134
null 130
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 129
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 124
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 120
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 116
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 114
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 111
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 110
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 109
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 107
Timing of therapies for downsyndrome: The sooner, the better 106
null 97
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 93
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 86
null 83
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 83
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 81
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 79
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 77
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 43
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 33
Neurogenesis impairment: An early developmental defect in Down syndrome 32
Totale 2.642
Categoria #
all - tutte 7.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020645 68 21 5 42 75 62 76 87 98 55 38 18
2020/2021419 54 17 10 69 10 20 10 42 51 48 23 65
2021/2022452 28 21 22 13 62 37 39 23 22 27 72 86
2022/2023702 56 127 35 87 46 66 17 48 109 7 54 50
2023/2024185 10 38 9 11 6 43 2 1 0 18 24 23
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 2.642